MedPath

The ability of strong albumin solution infused intravenously to allocate fluid from the tissues to the cirkulation in healthy subjects and in burn patients

Phase 1
Conditions
Healthy adult volunteers and burn patients 3 to 10 Days after the injury.
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2016-000996-26-SE
Lead Sponsor
Region Ostergotland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Healthy volunteers
Burn patients 3 to 10 Days after the injury.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients with serious cardiac or pulmonary disease.
Health stats corresponding to American Society of Anesthesiologists (ASA) Group III and IV.
Inability to understand instructions.
Dementia.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath